Producer
Extractas Bioscience (formerly Tasmanian Alkaloids)
3
Inputs supplied
1
Goods downstream
1
Facilities
1
Stories
What they make
3 inputs Extractas Bioscience (formerly Tasmanian Alkaloids) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Extractas Bioscience (formerly Tasmanian Alkaloids) makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Poppy Cultivation and Procurement
30%Alkaloid Extraction and Refining
55%Specialty and Veterinary Alkaloids
15%
Stories from the supply chain
Editorial about Extractas Bioscience (formerly Tasmanian Alkaloids)
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2023
The same thebaine extracted from poppies grown on a Tasmanian island — by Extractas Bioscience, a company most Americans have never heard of — is the molecular precursor for oxycodone (the opioid at the center of the addiction epidemic), buprenorphine (the primary medication used to treat that addiction), and naloxone (the antidote used to reverse opioid overdoses). Every side of the opioid crisis — the drug, the treatment, and the rescue — flows from the same Australian raw material supply chain. A single weather event, crop failure, or regulatory action affecting Tasmanian poppy fields would simultaneously constrain all three.
International Narcotics Control Board (INCB) ↗Origin2022
Tasmania's dominance in global thebaine production is not accidental — it is the product of deliberate agricultural policy and the island's unique phytosanitary status. Tasmania is geographically isolated from wild Papaver somniferum (common opium poppy) populations, which means cross-pollination of the proprietary Norman high-thebaine cultivar with wild poppies cannot occur. This genetic purity is irreplaceable: the Norman variety was developed by Australian researchers in the 1960s specifically to produce high thebaine yields with minimal morphine — a profile impossible to replicate elsewhere without decades of plant breeding in an equivalent isolation zone. The island's licit poppy industry now supplies approximately 40-50% of global thebaine and oripavine under international narcotics control treaties.
United Nations Office on Drugs and Crime ↗Capacity2023
Extractas Bioscience's Westbury (Tasmania) facility processes poppy straw from approximately 12,000–15,000 hectares of contracted farm acreage in northern Tasmania annually. Total Tasmanian opiate production fluctuates with weather: the 2019-20 drought cut yields by ~30%, creating downstream API shortfalls for opioid manufacturers in the US and Europe. Tasmania's annual crop represents an estimated 500–700 metric tons of thebaine equivalent — roughly half the world's licit supply — produced under Australian Therapeutic Goods Administration (TGA) oversight and INCB international narcotics treaty compliance.
International Narcotics Control Board ↗